Insider information

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors > Insider information

Insider information

20. September 2017

Epigenomics AG issues new shares by way of private placement

Read more

07. August 2017

Epigenomics AG: Notice of Loss pursuant to § 92 par. 1 AktG

Read more

06. July 2017

Epigenomics AG issues change in guidance for financial year 2017

Read more

Press releases

22. October 2018

Centers for Medicare & Medicaid Services publish final rate of $192 for Epigenomics’ colorectal cancer screening blood test Epi proColon®

Read more

08. October 2018

Epigenomics AG: Capital increase through rights issue with subscription rights of existing shareholders

Read more

02. October 2018

Epigenomics AG: U.S. Congress supports CMS coverage of colorectal cancer screening blood tests

Read more